Skip to main content
. 2020 May 14;21(10):3480. doi: 10.3390/ijms21103480

Figure 1.

Figure 1

Interconnection between obesity and major metabolic disorders and the corresponding tissues that can be targeted by metabolic disrupting chemicals (MDCs). NAFLD: non-alcoholic fatty liver disease; WAT: white adipose tissue, SM: skeletal muscle.